公开(公告)号：US20250025631A1

公开(公告)日：2025-01-23

申请号：US18909572

申请日：2024-10-08

Applicant: INSULET CORPORATION

Inventor： James GRAHAM ,  Joon Bok LEE ,  Jason O'CONNOR

IPC: A61M5/172 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1495 ,  A61M5/142 ,  A61M5/168 ,  G16H10/60 ,  G16H20/00 ,  G16H20/10 ,  G16H20/17 ,  G16H40/67

Abstract: Disclosed are techniques and a device operable to determine a total amount of insulin delivered to the user over a predetermined time period. The total amount of insulin includes a total basal dosage delivered in basal dosages and a total bolus dosage delivered in bolus dosages over the predetermined time period. A proportion of the total amount of insulin delivered to the user provided via the total basal dosage amount over the predetermined time period is calculated. In response determining the proportion of the total amount of insulin attributed to the total basal dosage amount of insulin exceeds a threshold, an average basal dosage to be delivered within a subsequent time period that is approximately equal to the threshold may be determined. An instruction may be generated and output to deliver a modified basal dosage that substantially maintains the average basal dosage over the subsequent time period.

公开(公告)号：US20230248909A1

公开(公告)日：2023-08-10

申请号：US18164669

申请日：2023-02-06

Applicant: INSULET CORPORATION

Inventor： Joon Bok LEE ,  James GRAHAM ,  Jason O'CONNOR ,  Yibin ZHENG

IPC: A61M5/172 ,  G16H20/17

CPC classification number: A61M5/1723 ,  G16H20/17 ,  A61M2202/0486 ,  A61M2205/52

Abstract: Disclosed are processes and techniques for a correction factor determination process for determining a correction factor for delivering a drug to a patient via a drug delivery device. For example, for an insulin delivery device, the disclosed techniques enable adjustment of the patient’s correction factor in real time based on the deviation of the patient’s glucose concentrations against clinically recommended targets. For example, a method for determining a correction factor may include determining an insulin action (Iaction) for a patient over a duration, the insulin action representing a total insulin metabolized, determining glucose information for the patient over the duration, the glucose information representing glucose activity, and determining an estimated correction factor (CFest) based on (glucose information) / (insulin action) for the duration. Other embodiments are described.

公开(公告)号：US20220023536A1

公开(公告)日：2022-01-27

申请号：US17377801

申请日：2021-07-16

Applicant: Insulet Corporation

Inventor： James GRAHAM ,  Joon Bok LEE ,  Jason O'CONNOR

IPC: A61M5/172 ,  G16H40/67 ,  G16H20/17 ,  G16H10/60

Abstract: Disclosed are techniques and a device operable to determine a total amount of insulin delivered to the user over a predetermined time period. The total amount of insulin includes a total basal dosage delivered in basal dosages and a total bolus dosage delivered in bolus dosages over the predetermined time period. A proportion of the total amount of insulin delivered to the user provided via the total basal dosage amount over the predetermined time period is calculated. In response determining the proportion of the total amount of insulin attributed to the total basal dosage amount of insulin exceeds a threshold, an average basal dosage to be delivered within a subsequent time period that is approximately equal to the threshold may be determined. An instruction may be generated and output to deliver a modified basal dosage that substantially maintains the average basal dosage over the subsequent time period.